Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
NASDAQ:KNSA
Want to see KNSA full AI Analyst Report?
Kiniksa Pharmaceuticals (KNSA) Ownership Overview
7.14% Insiders
20.05% Mutual Funds
36.29% Other Institutional Investors
10.61% ETFs
25.92% Public Companies and Individual Investors
The ownership structure of Kiniksa Pharmaceuticals (KNSA) stock is a mix of institutional, retail, and individual investors. Approximately 66.94% of the company’s stock is owned by Institutional Investors, 7.14% is owned by Insiders, and 25.92% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 14, 2025 | xxxxxxxxxxxxx | $5859815 | |
Jun 11, 2025 | xxxxxxxxxxxxx | $833001 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $1011150 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $20655002 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $29438814 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,888,391 | Institution | 6.24% | 154,962,177 | |
| 2,826,246 | Institution | 6.10% | 151,628,098 | |
| 2,768,496 | Insider | 5.98% | 148,529,810 | |
| 2,671,138 | Institution | 5.77% | 143,306,554 | |
| 1,319,688 | Institution | 2.85% | 70,801,261 | |
| 1,067,500 | Institution | 2.31% | 57,271,375 | |
| 1,020,139 | Institution | 2.20% | 54,730,457 | |
| 937,057 | Institution | 2.02% | 50,273,108 | |
| 611,398 | Institution | 1.32% | 32,801,503 | |
| 522,983 | Institution | 1.13% | 28,058,038 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,671,138 | Institution | 5.77% | 143,306,554 | |
| 1,067,500 | Institution | 2.31% | 57,271,375 | |
| 937,057 | Institution | 2.02% | 50,273,108 | |
| 522,983 | Institution | 1.13% | 28,058,038 | |
| 394,989 | Institution | 0.85% | 21,191,160 | |
| 389,911 | Institution | 0.84% | 20,918,725 | |
| 361,477 | Institution | 0.78% | 19,393,241 | |
| 332,836 | Institution | 0.72% | 17,856,651 | |
| 311,881 | Institution | 0.67% | 16,732,416 | |
| 298,137 | Institution | 0.64% | 15,995,050 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,289,998 | Institution | 2.79% | 62,113,404 | |
| 955,020 | Institution | 2.06% | 45,984,213 | |
| 535,190 | Institution | 1.16% | 25,769,399 | |
| 150,667 | Institution | 0.33% | 8,794,433 | |
| 150,667 | Institution | 0.33% | 8,794,433 | |
| 148,468 | Institution | 0.32% | 8,666,077 | |
| 140,266 | Institution | 0.30% | 8,187,326 | |
| 140,266 | Institution | 0.30% | 8,187,326 | |
| 140,266 | Institution | 0.30% | 8,187,326 | |
| 127,131 | Institution | 0.27% | 5,656,058 |
FAQ
Who Owns Kiniksa Pharmaceuticals Ltd. Class A (KNSA)?
According to the latest TipRanks data, approximately 36.29% of the company's stock is held by institutional investors, 7.14% is held by insiders, and 25.92% is held by retail investors.
What percentage of Kiniksa Pharmaceuticals Ltd. Class A (KNSA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 36.29% of Kiniksa Pharmaceuticals Ltd. Class A (KNSA) stock is held by institutional investors.
What percentage of Kiniksa Pharmaceuticals Ltd. Class A (KNSA) stock is held by retail investors?
According to the latest TipRanks data, approximately 25.92% of Kiniksa Pharmaceuticals Ltd. Class A (KNSA) stock is held by retail investors.
Who owns the most shares of Kiniksa Pharmaceuticals Ltd. Class A (KNSA)?
Vanguard owns the most shares of Kiniksa Pharmaceuticals Ltd. Class A (KNSA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.